Cabazitaxel in recurrent/metastatic squamous cell carcinoma of the head and neck: phase II UNICANCER trial ORL03

Jerome Fayette; Joel Guigay; Christophe Le Tourneau; Marian Degardin; Frederic Peyrade; Eve-Marie Neidhardt; Marie-Paule Sablin; Caroline Even; Florence Orlandini; Béata Juzyna; Carine Bellera

doi:10.18632/oncotarget.15901

Cabazitaxel in recurrent/metastatic squamous cell carcinoma of the head and neck: phase II UNICANCER trial ORL03

Oncotarget ◽

10.18632/oncotarget.15901 ◽

2017 ◽

Vol 8 (31) ◽

pp. 51830-51839 ◽

Cited By ~ 2

Author(s):

Jerome Fayette ◽

Joel Guigay ◽

Christophe Le Tourneau ◽

Marian Degardin ◽

Frederic Peyrade ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.14264023.15777137 ◽

2012 ◽

Author(s):

Marco Merlano

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Clinical Activity ◽

Molecular Response ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of the head and neck (E1304): a trial of the Eastern Cooperative Oncology Group.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954085.793459863 ◽

2012 ◽

Author(s):

Marco Merlano

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Proteasome Inhibitor ◽

Eastern Cooperative Oncology Group ◽

Oncology Group ◽

Metastatic Squamous Cell Carcinoma ◽

Locally Recurrent

Download Full-text

Faculty Opinions recommendation of Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954885.793461177 ◽

2012 ◽

Author(s):

Sandra Nuyts

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Preclinical Data ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Phase II study of vinorelbine/cetuximab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck progressing after at least two chemotherapy regimens

Oral Oncology ◽

10.1016/j.oraloncology.2010.08.013 ◽

2010 ◽

Vol 46 (11) ◽

pp. 818-821 ◽

Cited By ~ 8

Author(s):

Elena Massa ◽

Mariele Dessì ◽

Giulio Gaspardini ◽

Federica Saba ◽

Valeria Cherchi ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

A phase II study of vinorelbine (VRL), cisplatin (CDDP) and 5-Fluorouracil (FU) in patients (PTS) with locally advanced recurrent, and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)

European Journal of Cancer ◽

10.1016/s0959-8049(99)81098-3 ◽

1999 ◽

Vol 35 ◽

pp. S176

Author(s):

V. Guillem ◽

M.A. Muñoz ◽

R. Yaya ◽

V. Soriano ◽

M.A. Climent ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Locally Advanced ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

A Non Platinum Regimen for the Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Region. Results From an Extended Phase II Study With Paclitaxel and Capecitabine

Frontiers in Oncology ◽

10.3389/fonc.2018.00243 ◽

2018 ◽

Vol 8 ◽

Author(s):

Jens K. D. Bentzen ◽

Claus Andrup Kristensen ◽

Marie Overgaard ◽

Carsten Rytter ◽

Kenneth Jensen ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Neck Region ◽

Extended Phase ◽

Head And Neck Region ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Abstract C166: Phase II study of cetuximab and lenalidomide in recurrent/metastatic squamous cell carcinoma of the head and neck.

10.1158/1535-7163.targ-13-c166 ◽

2013 ◽

Author(s):

Rodney J. Taylor ◽

Vassiliki Saloura ◽

Richard Wong ◽

Olga Goloubeva ◽

Lorna Silpino ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Patritumab or placebo, with cetuximab plus platinum therapy in recurrent or metastatic squamous cell carcinoma of the head and neck: A randomised phase II study

European Journal of Cancer ◽

10.1016/j.ejca.2019.08.017 ◽

2019 ◽

Vol 123 ◽

pp. 36-47 ◽

Cited By ~ 2

Author(s):

Martin D. Forster ◽

Magnus T. Dillon ◽

Judit Kocsis ◽

Éva Remenár ◽

Gabor Pajkos ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02)

Annals of Oncology ◽

10.1093/annonc/mdr574 ◽

2012 ◽

Vol 23 (8) ◽

pp. 2153-2161 ◽

Cited By ~ 48

Author(s):

S. Schmitz ◽

M.-C. Kaminsky-Forrett ◽

S. Henry ◽

S. Zanetta ◽

L. Geoffrois ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Clinical Activity ◽

Molecular Response ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Phase II Trial of Gefitinib 250 mg Daily in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-05-1247 ◽

2005 ◽

Vol 11 (23) ◽

pp. 8418-8424 ◽

Cited By ~ 168

Author(s):

Ezra E.W. Cohen ◽

Madeleine A. Kane ◽

Marcy A. List ◽

Bruce E. Brockstein ◽

Bhoomi Mehrotra ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Metastatic Squamous Cell Carcinoma

Download Full-text